Tata Group to invest ₹110 cr in Karkinos
- ByStartupStory | September 25, 2021
Karkinos, a comprehensive oncology platform has closed a funding round with Tatas with an investment commitment of Rs 110 crore, according to industry sources.
Tata group plans to invest about Rs 35 crore immediately and put in the rest of the capital in tranches, to take a minority stake in Karkinos Healthcare.
Karkinos, founded by former Tata staff members R Venkataramanan and Ravi Kant together with former BCCI Main Operating Officer Sundar Raman, also has health-related entrepreneur Shahvir Nooryezdan and Avanti Finance COO, Manish Thakkar as its co-founders.
The Mumbai-based Karkinos Center focuses on meeting clinical needs through a digital distributed network, which will bring high-quality care closer to patients in cancer care.
The health care platform is also finalising a further spherical of funding from some of the primary company leaders, including Ratan Tata, Venu Srinivasan, Ronnie Screwvala, Bhavish Aggarwal amid many others, sources said.
The company is pioneering the Distributed Cancer Care Network model in India which was recently found mention in Lancet Oncology, a leading medical journal.
The company is already providing its services in Kothamangalam, Chotanikkara, and Todhapouzha in the Ernakulam district of Kerala and aims to ramp up its operations during the year.
The Tatas have been aggressively pursuing their curiosity in healthcare with green industry and brown discipline ventures.
They have forayed into Covid testing and diagnostics with Tata Medical, teleconsultation with Tata Health, and acquired a majority stake in online pharmacy company 1MG which has subsequently been rebranded as Tata1MG.
Also Read
Follow Startup Story
Related Posts
